A perceval pvs25 was implanted on (b)(6) 2018.It was reported that the surgeon had some difficulty collapsing the valve.After several tries to collapse the valve, the valve looked imperfect on the holder and the stent was reportedly not symmetrical.The valve was implanted, and the visual aspect then appeared correct.It was stated that after decannulation, while the patient was in icu, a leak was identified.Re-operation was performed and the valve was explanted and replaced with a trifecta valve (size unknown).It was reported that there was a "crimping defect" of the valve; however, it could not be confirmed that the valve was folded at the time of re-operation.It was reported that the valve may not have been correctly implanted in the annulus.
|
A complete review of the manufacturing and quality control data filed in the device history record of the perceval heart valve prosthesis, pvs 25/l, sn (b)(4), confirmed that the valve satisfied all material, dimensional and performance standards required for a size 25/l perceval heart valve at the time of manufacture and release.The valve was received in non-standard packaging conditions in a dry, under-sized jar.The pericardium was darkened and slightly dehydrated, although the leaflets were pliable.Visual inspection of the returned device, although partly dehydrated, did not reveal any anomalies attributable to pre-existing manufacturing defects.An attempt was made to simulate the reported issue; however, the dehydrated state of the returned device rendered the simulation of the reported event impossible.Due to the deeply altered state of the valve, an exhaustive investigation of the reported event could not be performed and the root cause of the event cannot be established.However, based on the document review performed, no manufacturing deficiencies were identified.
|